Consistent with this, the prevalence of CD69- and IFN-γ-producing CMVp-CTLs among the tumor-infiltrating cells was substantially higher after treatment with either inCT†CMVp480–503 or inCT†CMVp480–516 than after treatment with the control substances (Fig. 3B). This evidence concerns the gene IFNG and neoplasm.